Differential long-term evolution after surgery or pharmacotherapy of Rasmussen encephalopathy in adult patients

  • Annalisa ParenteEmail author
  • Chiara Pastori
  • Flavio Villani
  • Anna Rita Giovagnoli
Letter to the Editors

Dear Sir,

Rasmussen encephalitis (RE) is a severe encephalopathy marked by a chronic brain inflammation including microglial nodules, perivascular infiltrates, neuronal loss and gliosis [1], which typically affects one hemisphere. Although clinical onset is usually in the childhood, some cases begin in the adolescence or young adulthood. Clinically, it is characterized by drug-resistant seizures, often epilepsia partialis continua (EPC) and epileptic status, motor and sensorial impairments, cognitive impairments secondary to progressive brain dysfunction. Magnetic resonance shows progressive unilateral atrophy of the cortex, caudate nucleus and signal alteration of the white matter. Treatment is aimed at controlling the seizures and stopping clinical worsening. To date, the surgical exclusion of the affected hemisphere has been the only therapeutic option to achieve both objectives [2, 3]. Functional hemispherectomy of the affected hemisphere is unanimously recognized as the treatment...


Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standard statement

The authors state that no approval by ethics committee is required for the issue of this letter, and that all applicable Italian laws have been observed.


  1. 1.
    Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, Vincent A, Mathern GW, Cross JH (2014) Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 13:195–205. CrossRefGoogle Scholar
  2. 2.
    Vining EP, Freeman JM, Pillas DJ, Uematsu S, Carson BS, Brandt J, Boatman D, Pulsifer MB, Zuckerberg A (1997) Why would you remove half a brain? The outcome of 58 children after hemispherectomy—the Johns Hopkins experience: 1968 to 1996. Pediatrics 100:163–171CrossRefGoogle Scholar
  3. 3.
    Kossoff EH, Vining EP, Pillas DJ, Pyzik PL, Avellino AM, Carson BS, Freeman JM (2003) Hemispherectomy for intractable unihemispheric epilepsy etiology vs outcome. Neurology 61:887–890. CrossRefGoogle Scholar
  4. 4.
    Bien CG, Schramm J (2009) Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 86(2–3):101–112. CrossRefGoogle Scholar
  5. 5.
    Villani F, Didato G, Deleo F, Tringali G, Garbelli R, Granata T, Marras CE, Cordella R, Spreafico R (2014) Long-term outcome after limited cortical resections in two cases of adult-onset Rasmussen encephalitis. Epilepsia 55(5):e38–e43. CrossRefGoogle Scholar
  6. 6.
    Stabile A, Deleo F, Didato G, Pastori C, Antozzi C, de Curtis M, Villani F (2018) Adult-onset Rasmussen encephalitis treated with mitoxantrone. Eur J Neurol 25(12):e125–e126. CrossRefGoogle Scholar
  7. 7.
    Giovagnoli AR, Parente A, Didato G, Manfredi V, Deleo F, Tringali G, Villani F (2014) The course of language functions after temporal lobe epilepsy surgery: s prospective study. Eur J Neurol 23:1713–1721. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.IRCCS Istituto Neurologico Carlo BestaMilanItaly

Personalised recommendations